Cellular and Molecular Treatments of Neurological Diseases

This publication has 15 references indexed in Scilit:

• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
  Nature, 1998
• Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson’s Disease
  Journal of Neuroscience, 1998
• Cellular Delivery of CNTF but not NT-4/5 Prevents Degeneration of Striatal Neurons in a Rodent Model of Huntington's Disease
  Cell Transplantation, 1998
• Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family
  Journal of Cerebral Blood Flow & Metabolism, 1998
• Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats
  Proceedings of the National Academy of Sciences, 1997
• Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease
  Nature, 1997
• Implants of Encapsulated Human CNTF-Producing Fibroblasts Prevent Behavioral Deficits and Striatal Degeneration in a Rodent Model of Huntington’s Disease
  Journal of Neuroscience, 1996
• Implantation of Polymer-Encapsulated Human Nerve Growth Factor-Secreting Fibroblasts Attenuates the Behavioral and Neuropathological Consequences of Quinolinic Acid Injections into Rodent Striatum
  Experimental Neurology, 1994
• Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease.
  Proceedings of the National Academy of Sciences, 1994
• Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurones
  Neuroscience Letters, 1992